Welcome to GLP123.ai

announcement

Welcome to GLP123.ai

We’re building the first truly neutral comparison tool for GLP-1 medication providers.

Over 30 million Americans have tried GLP-1 medications like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound). More than half say they’re hard to afford. And yet, every “comparison” site online is really just an affiliate-driven listicle ranking whoever pays the most.

GLP123.ai is different. We compare telehealth providers on real pricing data - medication costs, membership fees, hidden fees, and true total monthly cost. No affiliate bias. No sponsored rankings. Just data.

What You’ll Find Here

  • Price Comparison Tool: Sort and filter providers by medication type, format (injection vs. oral), dose, and total monthly cost.
  • Pricing Guides: Deep dives into the cheapest options for semaglutide and tirzepatide.
  • Industry News: Coverage of FDA decisions, compounding regulations, and patent expirations that affect your options.
  • Educational Content: Understanding 503A vs 503B pharmacies, compounded vs brand-name medications, and how to verify your provider.

Coming Soon

We’re actively working on expanding our data set, adding state-by-state availability filters, and building provider detail pages with full pricing breakdowns.

This site is for informational purposes only and does not provide medical advice.